Perlecan domain v therapy for stroke: A beacon of hope?

ACS Chemical Neuroscience

Volumn 4, Issue 3, 2013, Pages 370-374

  Bix, Gregory J ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

angiogenesis; astrogliosis; neurogenesis; neuroprotection; perlecan; Stroke

Indexed keywords

PERLECAN; PERLECAN DOMAIN V; UNCLASSIFIED DRUG; VASCULOTROPIN; VERY LATE ACTIVATION ANTIGEN 2;

ACUTE DISEASE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; BRAIN PROTECTION; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; CLINICAL TRIAL (TOPIC); DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; DRUG PENETRATION; DRUG RESEARCH; HUMAN; NERVE REGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ACUTE DISEASE; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; MICE; NEUROPROTECTIVE AGENTS; RATS; STROKE;

ANIMALIA; MUS; RATTUS; RODENTIA;

EID: 84875496877     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn300197y     Document Type: Review

References (33)

1. Palomares, S. M. and Cipolla, M. J. (2011) Vascular protection following cerebral ischemia reperfusion J. Neurol. Neurophysiol. S1 004
2. Yamashgita, T., Kamiya, T., Deguchi, K., Inaba, T., Zhang, H., Shang, J., Miyazaki, K., Ohtsuka, A., Katayama, Y., and Abe, K. (2009) Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain J. Cereb. Blood Flow Metab. 29, 715-725
3. Manawadu, D., Bodla, S., Jarosz, J., and Kalra, L. Thrombolysis in selected patients with wake up stroke is feasible with similar safety as thrombolysis in 0-4.5 h. Presented at the International Stroke Conference, Abstract, 2012.
4. Armstead, W. M., Ganguly, K., Kiessling, J. W., Riley, J., Chen, X. H., Smith, D. H., Stein, S. C., Higazi, A. A., Cines, D. B., Bdeir, K., Zaitsev, S., and Muzykantov, V. R. (2010) Signaling, delivery and age as emerging issues in the benefit\risk ratio outcome of tPA for treatment of CNS ischemic disorders J. Neurochem. 113, 303-312
5. Ansari, S., Rahman, M., McConnell, D. J., Waters, M. F., Hoh, B. L., and Mocco, J. (2011) Recanalization therapy for acute ischemic stroke, part 2: Mechanical intra-arterial technologies Neurosurg. Rev. 34, 11-20
6. Sharkey, J., Richie, I., and Kelley, P. (1993) Perivascular microapplication of endothelin-1: A new model of focal cerebral ischaemia in the rat J. Cereb. Blood Flow Metab. 13, 865-871
7. Sharkey, J. and Butcher, S. (1995) Characterisation of an experimental model of stroke produced by intracerebral microinjection of endothelin-1 adjacent to the rat middle cerebral artery J. Neurosci. Methods 60, 125-131
8. Lo, E. H. (2008) A new penumbra: Transitioning from injury into repair after stroke Nat. Med. 14, 497-500
9. Zhang, Z. G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, N., and Chopp, M. (2000) VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain J. Clin. Invest. 106, 829-838
10. Hansen, T., Moss, A., and Brindle, N. (2008) Vascular endothelial growth factor and angiopoietins in neurovascular regeneration and protection following stroke Curr. Neurovasc. Res. 5, 235-244
11. Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A., and Greenberg, D. A. (2003) VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia J. Clin. Invest. 111, 1843-1851
12. Wang, X., Rossell, A., and Lo, E. H. (2008) Targeting extracellular matrix proteolysis for hemorrhagic complications of tPA stroke therapy CNS Neurol. Disord.: Drug Targets 7, 235-242
13. Roberts, J., Kahle, M. P., and Bix, G. J. (2012) Perlecan and the blood-brain barrier: Beneficial proteolysis? Front. Pharmacol. 3, 1-5
14. Tian, H. L., Chen, H., Cui, Y. H., Xu, T., and Zhou, L. F. (2007) Increased protein and mRNA expression of endostatin in the ischemic brain tissue of rabbits after middle cerebral artery occlusion Neurosci. Bull. 23, 35-40
15. Bix, G. and Iozzo, R. (2008) Novel interactions of perlecan: Unraveling perlecan's role in angiogenesis Microsc. Res. Tech. 71, 339-348
16. Mongiat, M., Sweeney, S., San Antonio, J. D., Fu, J., and Iozzo, R. V. (2003) Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan J. Biol. Chem. 278, 4238-4249
17. Fukuda, S., Fini, C. A., Mabuchi, T., Koziol, J. A., Eggleston, L. L., Jr., and del Zoppo, G. J. (2004) Focal cerebral ischemia induces active proteases that degrade microvascular matrix Stroke 35, 998-1004
18. Lee, B., Clarke, D., Al Ahmad, A., Kahle, M., Parham, C., Auckland, L., Shaw, C., Fidanboylu, M., Orr, A. W., Ogunshola, O., Fertala, A., Thomas, S. A., and Bix, G. (2011) Perlecan domain V is neuroprotective and pro-angiogenic following ischemic brain stroke in rodents J. Clin. Invest. 121, 3005-3023
19. Bix, G., Castello, R., Burrows, M., Zoeller, J. J., Weech, M., Iozzo, R. A., Cardi, C., Thakur, M. T., Barker, C. A., Camphausen, K. C., and Iozzo, R. V. (2006) Endorepellin in vivo: Targeting the tumor vasculature and retarding cancer growth and metabolism J. Natl. Cancer Inst. 98, 1634-1646
20. Al-Ahmad, A. J., Lee, B., Saini, M., and Bix, G. J. (2011) Perlecan domain V modulates astrogliosis in vitro and after focal cerebral ischemia through multiple receptors and increased nerve growth factor release Glia 59, 1822-1840
21. Goyal, A., Poluzzi, C., Smythies, J., Shellard, A., Neill, T., and Iozzo, R. V. (2012) Endorepellin affects angiogenesis by antagonizing diverse VEGFR2-evoked signaling pathways: transcriptional repression of HIF-1a and VEGFA and concurrent inhibition of NFAT activation J. Biol. Chem. jbc.M112.401786
22. Clarke, D. N., Al Ahmad, A., Lee, B., Parham, C., Auckland, L., Fertala, A., Kahle, M., Shaw, C. S., Roberts, J., and Bix, G. J. (2012) Perlecan domain V induces VEGF secretion in brain endothelial cells through integrin a5b1 and ERK-dependent signlaing pathways PLoS One 7, e45257
23. Saini, M., Pinteaux, E., Lee, B., and Bix, G. (2011) Oxygen-glucose deprivation and interleukin-1a trigger the release of perlecan LG3 by cells of neurovascular unit J. Neurochem. 119, 760-771
24. Gonzalez, E. M., Reed, C. C., Bix, G., Fu, J., Zhang, Y., Gopalakrishnan, B., Greenspan, D. S., and Iozzo, R. V. (2005) BMP-1/Tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan J. Biol. Chem. 280, 7080-7087
25. Milner, R., Hung, S., Xiaoyun, W., Berg, G., Spatz, M., and del Zoppo, G. (2008) Responses of endothelial cell and astrocyte matrix-integrin receptors to ischemia mimic those observed in the neurovascular unit Stroke 39, 191-197
26. van Velthoven, C. T. J., Heijhen, C. J., van Bel, F., and Kavelaars, A. (2011) Osteopontin enhances endogenous repair after neonatal hypoxic-ischemic brain injury Stroke 42, 2294-2301
27. Wang, X., Louden, C., Yue, T. L., Ellison, J. A., Barone, F. C., Solleveld, H. A., and Feuerstein, G. Z. (1998) Delayed expression of osteopontin after focal stroke in the rat J. Neurosci. 18, 2075-2083
28. Meller, R., Stevens, S. L., Minami, M., Cameron, J. A., King, S., Rosenzweig, H., Doyle, K., Lessov, N. S., Simon, R. P., and Stenzel-Poore, M. P. (2005) Neuroprotection by osteopontin in stroke J. Cereb. Blood Flow Metab. 25, 217-225
29. Chen, W., Ma, Q., Suzuki, H., Hartman, R., Tang, J., and Zhang, J. H. (2011) Osteopontin reduced hypoxia-ischemia neonatal brain injury by suppression of apoptosis in a rat pup model Stroke 42, 764-769
30. Yan, Y. P., Lang, B. T., Vemuganti, R., and Dempsey, R. J. (2009) Osteopontin is a mediator of the lateral migration of neuroblasts from the subventricular zone after focal cerebral ischemia Neurochem. Int. 55, 826-832
31. Doyle, K. P., Yang, T., Lessov, N. S., Ciesielski, T. M., Stevens, S. L., Simon, R. P., King, J. S., and Stenzel-Poore, M. P. (2008) Nasal administration of osteopontin peptide mimetics confers neuroprotection in stroke J. Cereb. Blood Flow Metab. 28, 1235-1248
32. Zhao, L. R., Spellman, S., Kim, J., Duan, W. M., McCarthy, J. B., and Low, W. C. (2005) Synthetic fibronectin peptide exerts neuroprotective effects on transient focal brain ischemia in rats Brain Res. 1054, 1-8
33. Sakai, T., Johnson, K., Murozono, M., Sakai, K., Magnuson, M., Wieloch, T., Cronberg, T., Isshiki, A., Erickson, H., and Fassler, R. (2001) Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis Nat. Med. 7, 324-330